Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tachyon Ventures is an active early-stage life science venture capital firm, focused on investing in innovative companies at the forefront of biotech, therapeutics, and healthcare technology, including those developing modalities such as gene therapy, CRISPR, and RNA-based therapeutics. It is not a drug development company itself, but invests in those that are.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tachyon Ventures.